Presynaptic voltage-gated potassium channel (VGKC)

Presynaptic voltage-gated potassium (Kv) channels, particularly those of the Kv1 (Shaker-related) subfamily such as Kv1.1 and Kv1.2, are essential for regulating electrical signaling at the motor nerve terminal. These channels open during the repolarization phase of an action potential, allowing potassium ions to flow out of the neuron, which restores the negative resting membrane potential and terminates the signal. By limiting the duration of the action potential, these channels control the window of time during which voltage-gated calcium channels remain open, thereby precisely modulating the amount of acetylcholine released into the neuromuscular junction. Dysfunction of these channels, often due to autoimmune antibodies in conditions like neuromyotonia (Isaac's syndrome), leads to nerve hyperexcitability and continuous muscle fiber activity. Conversely, in Lambert-Eaton myasthenic syndrome (LEMS), where acetylcholine release is impaired, pharmacological blockers of these channels are used to prolong the action potential and enhance neurotransmission. Drugs such as amifampridine (3,4-diaminopyridine) target these channels to increase the influx of calcium and boost the release of acetylcholine, effectively improving muscle strength in affected patients.

Other names

Voltage-gated potassium channelKv channelShaker-related potassium channelPotassium voltage-gated channel subfamily A member 1 (Kv1.1)Potassium voltage-gated channel subfamily A member 2 (Kv1.2)Voltage-gated potassium channel complex (VGKCC)

Potassium channel blocker